A part of the MAPK Pathway, ERK2 is phosphorylated at Thr185 and Tyr187 by the mitogen-activated protein kinase kinases 2 (MAP2K2) .
For use in combination with the LanthaScreen™ ERK2 A375 cell line (K1798) to evaluate inhibitors in medium to high throughput screening applications.